Revised response based on immunostains: Chronic lymphocytic leukemia/small lymphocytic lymphoma, mantle cell lymphoma, atypical chronic lymphocytic leukemia, CD5+ marginal zone lymphoma, other low-grade B-cell lymphoma. Here, CD5 is linked to marginal zone lymphoma.